The Hippo effector YAP regulates the response of cancer cells to MAPK pathway inhibitors

被引:28
|
作者
Lin, Luping [1 ,2 ]
Bivona, Trever G. [1 ,2 ]
机构
[1] Univ Calif San Francisco, Div Hematol & Med Oncol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
来源
MOLECULAR & CELLULAR ONCOLOGY | 2016年 / 3卷 / 01期
关键词
BRAF; Hippo; MEK; resistance; RAS; targeted therapy; YAP;
D O I
10.1080/23723556.2015.1021441
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
RAF- and MEK-targeted therapies are approved for patients with BRAFV600E melanoma and under investigation in a several other tumor types, but resistance remains a major challenge. We uncovered yes-associated protein 1 (YAP1) as a mechanism of resistance to RAF-MEK inhibition in BRAF- and RAS-mutant cancers, providing a rationale for co-targeting YAP and RAF-MEK to enhance patient outcomes.
引用
收藏
页数:2
相关论文
共 50 条
  • [31] YAP part of the hippo pathway is overexpressed in pancreatic cancer
    Grote, T.
    Gaiser, S.
    Wang, H.
    Halder, G.
    Logsdon, C.
    PANCREAS, 2007, 35 (04) : 404 - 404
  • [32] Multiple roles for the hippo effector yap in gut regeneration and cancer initiation
    Gregorieff, Alex
    Wrana, Jeffrey L.
    MOLECULAR & CELLULAR ONCOLOGY, 2016, 3 (03):
  • [33] CDK7 regulates organ size and tumor growth by safeguarding the Hippo pathway effector Yki/Yap/Taz in the nucleus
    Cho, Yong Suk
    Li, Shuang
    Wang, Xiaohui
    Zhu, Jian
    Zhuo, Shu
    Han, Yuhong
    Yue, Tao
    Yang, Yingzi
    Jiang, Jin
    GENES & DEVELOPMENT, 2020, 34 (1-2) : 53 - 71
  • [34] The MAPK Pathway Regulates Intrinsic Resistance to BET Inhibitors in Colorectal Cancer
    Ma, Yufang
    Wang, Lihong
    Neitzel, Leif R.
    Loganathan, Sudan N.
    Tang, Nan
    Qin, Lili
    Crispi, Emily E.
    Guo, Yan
    Knapp, Stefan
    Beauchamp, R. Daniel
    Lee, Ethan
    Wang, Jialiang
    CLINICAL CANCER RESEARCH, 2017, 23 (08) : 2027 - 2037
  • [35] SUFU suppresses ferroptosis sensitivity in breast cancer cells via Hippo/YAP pathway
    Fang, Kun
    Du, Sha
    Shen, Dachuan
    Xiong, Zhipeng
    Jiang, Ke
    Liang, Dapeng
    Wang, Jianxin
    Xu, Huizhe
    Hu, Lulu
    Zhai, Xingyue
    Jiang, Yuting
    Xia, Zhiyu
    Xie, Chunrui
    Jin, Di
    Cheng, Wei
    Meng, Songshu
    Wang, Yifei
    ISCIENCE, 2022, 25 (07)
  • [36] Bufalin inhibits the proliferation of lung cancer cells by suppressing Hippo-YAP pathway
    Qian, Zijun
    Tian, Xiaoting
    Miao, Yayou
    Xu, Xin
    Cheng, Xuehua
    Wu, Mengyi
    Yu, Yongchun
    CELLULAR SIGNALLING, 2023, 109
  • [37] The Hippo signaling pathway effector YAP promotes salivary gland regeneration after injury
    Rocchi, Cecilia
    Cinat, Davide
    Martinez, Paola Serrano
    Jellema-de Bruin, Anne L.
    Baanstra, Mirjam
    Brouwer, Uilke
    Zuivre, Cinthya del Angel
    Schepers, Hein
    van Os, Ronald
    Barazzuol, Lara
    Coppes, Robert P.
    SCIENCE SIGNALING, 2021, 14 (712)
  • [38] The hippo pathway effector TAZ regulates ferroptosis in renal cell carcinoma
    Yang, Wen-Hsuan
    Chi, Jen-Tsan
    CANCER RESEARCH, 2019, 79 (13)
  • [39] The Hippo Pathway Effector TAZ Regulates Ferroptosis in Renal Cell Carcinoma
    Yang, Wen-Hsuan
    Ding, Chien-Kuang Cornelia
    Sun, Tianai
    Rupprecht, Gabrielle
    Lin, Chao-Chieh
    Hsu, David
    Chi, Jen-Tsan
    CELL REPORTS, 2019, 28 (10): : 2501 - +
  • [40] The Hippo Pathway Effector Yap Controls Patterning and Differentiation of Airway Epithelial Progenitors.
    Cardoso, W. V.
    MOLECULAR BIOLOGY OF THE CELL, 2014, 25